Author

Omid Hamid

Cedars-Sinai Medical CenterORCID 0000-0002-8238-4655Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Assay:metabolomics· 1

Frequent Co-Authors

Hyungsoo KimiD· 3 shared Ze’ev A. RonaiiD· 3 shared Aagam S. ShahiD· 2 shared Eytan RuppiniD· 2 shared Hyunjeong JooiD· 2 shared Mark B. FariesiD· 2 shared Saugato Rahman DhrubaiD· 2 shared Simon KnottiD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Hyungsoo KimORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCell Reports MedicinePeer-reviewedJul 1, 2026

Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth

Ximena Diaz Olea, Kristin A Beede, Gabriel Vasconcelos Pereira…·Ze’ev A. Ronai

This study shows that intestinal Bacteroides species degrade tryptophan into indoles, which enhance anti-tumor immunity and limit melanoma growth.

DOI 10.1016/j.xcrm.2026.102921

mousemetabolomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 27, 2025

Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathology

Sumit Mukherjee, Sumeet Patiyal, Lipika R. Pal…·Eytan Ruppin

This paper introduces TIME_ACT, a transcriptomic signature predicting immune checkpoint blockade response across cancers, validated using histopathology and multiple cohorts.

DOI 10.1101/2025.06.27.661875

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 20, 2024

Targeting the translation initiation complex in therapy-resistant and metastatic melanoma

Yongmei Feng, Ximena Diaz-Olea, Xiurong Ke…·Ze’ev A. Ronai

This study identifies M19-6 as a small molecule that disrupts the eIF4F complex, reducing melanoma growth and metastasis while sparing melanocytes.

DOI 10.1101/2024.11.20.624566

humanbulk RNA-seq

𝕏 PostBluesky